Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia

Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Jenny Shan, Farhad Ravandi, Tapan Kadia, Stefan Faderl, Guillermo Garcia-Manero, Gautam Borthakur, Jorge Cortes

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences